Insights

Global Clinical Reach Smooth Drug Development operates as a one stop service across Europe and Asia with a broad geographic coverage including EAEA, multiple EU countries, Turkey, India, Pakistan, and China. This presents a sales opportunity to offer integrated trial management and registration services to biopharma navigating cross-region submissions and vendor outsourcing under ISO 9001:2015 aligned quality.

Full-Service Offer The company provides end-to-end clinical trial support—from consulting and pre-clinical work to registration, post-marketing surveillance and pharmacovigilance, plus eClinical solutions (ePRO, eTMF/eISF) and training. This creates upsell potential for clients seeking a single vendor for multi-phase development and ongoing safety monitoring.

Tech-Driven Trials Distinctive IT suite including Smooth CTMS with EDC/eSource, eTMF/eISF, ePRO, QMS and monitoring modules indicates a strong efficiency angle. sales conversations can emphasize reduced cycle times, streamlined data management, and compliance via integrated technology stack.

Quality and Compliance ISO certifications for quality, information security, and business continuity reinforce reliability for global sponsors, especially those with stringent regulatory and data protection requirements. This can be a key differentiator when pursuing risk-averse customers and late-stage programs.

Strategic Targeting With clients in Europe, US, CIS and Asia-Pacific and a mid-size employee base, Smooth Drug Development is positioned to target mid-market sponsors and emerging biotech, CROs seeking regional expertise and centralized management. There are cross-sell opportunities to expand pharmacovigilance, regulatory support, and central lab services to existing relationships.

Similar companies to Smooth Drug Development, next generation e-CRO in the US, Europe and Asia

Smooth Drug Development, next generation e-CRO in the US, Europe and Asia Tech Stack

Smooth Drug Development, next generation e-CRO in the US, Europe and Asia uses 8 technology products and services including Cloudflare DNS, Google Workspace, Microsoft 365, and more. Explore Smooth Drug Development, next generation e-CRO in the US, Europe and Asia's tech stack below.

  • Cloudflare DNS
    Domain Name Services
  • jQuery
    Javascript Libraries
  • Google Maps
    Maps
  • CentOS
    Operating Systems
  • PHP
    Programming Languages
  • Apache
    Web Servers

Smooth Drug Development, next generation e-CRO in the US, Europe and Asia's Email Address Formats

Smooth Drug Development, next generation e-CRO in the US, Europe and Asia uses at least 3 email formats:
Smooth Drug Development, next generation e-CRO in the US, Europe and Asia Email FormatsExamplePercentage
Last@smoothdd.comDoe@smoothdd.com
78%
First@smoothdd.comJohn@smoothdd.com
11%
FLast@smoothdd.comJDoe@smoothdd.com
11%

Frequently Asked Questions

What is Smooth Drug Development, next generation e-CRO in the US, Europe and Asia's official website and social media links?

Minus sign iconPlus sign icon
Smooth Drug Development, next generation e-CRO in the US, Europe and Asia's official website is smoothdd.com and has social profiles on LinkedIn.

How much revenue does Smooth Drug Development, next generation e-CRO in the US, Europe and Asia generate?

Minus sign iconPlus sign icon
As of October 2026, Smooth Drug Development, next generation e-CRO in the US, Europe and Asia's annual revenue is estimated to be $1B - $10B.

What is Smooth Drug Development, next generation e-CRO in the US, Europe and Asia's SIC code and NAICS code?

Minus sign iconPlus sign icon
Smooth Drug Development, next generation e-CRO in the US, Europe and Asia's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Smooth Drug Development, next generation e-CRO in the US, Europe and Asia have currently?

Minus sign iconPlus sign icon
As of October 2026, Smooth Drug Development, next generation e-CRO in the US, Europe and Asia has approximately 62 employees across 5 continents, including Asia, North America and Europe. Key team members include Ceo: D. M., Chief Operating Officer: K. A. and Head Of It Department: D. F. Explore Smooth Drug Development, next generation e-CRO in the US, Europe and Asia's employee directory with LeadIQ.

What industry does Smooth Drug Development, next generation e-CRO in the US, Europe and Asia belong to?

Minus sign iconPlus sign icon
Smooth Drug Development, next generation e-CRO in the US, Europe and Asia operates in the Biotechnology Research industry.

What technology does Smooth Drug Development, next generation e-CRO in the US, Europe and Asia use?

Minus sign iconPlus sign icon
Smooth Drug Development, next generation e-CRO in the US, Europe and Asia's tech stack includes Cloudflare DNS, Google Workspace, Microsoft 365, jQuery, Google Maps, CentOS, PHP and Apache.

What is Smooth Drug Development, next generation e-CRO in the US, Europe and Asia's email format?

Minus sign iconPlus sign icon
Smooth Drug Development, next generation e-CRO in the US, Europe and Asia's email format typically follows the pattern of Last@smoothdd.com. Find more Smooth Drug Development, next generation e-CRO in the US, Europe and Asia email formats with LeadIQ.

When was Smooth Drug Development, next generation e-CRO in the US, Europe and Asia founded?

Minus sign iconPlus sign icon
Smooth Drug Development, next generation e-CRO in the US, Europe and Asia was founded in 2008.
Smooth Drug Development, next generation e-CRO in the US, Europe and Asia logo

Smooth Drug Development, next generation e-CRO in the US, Europe and Asia

Biotechnology ResearchDelaware, United States51-200 Employees

Smooth Drug Development is a mid-sized biotechnology research company headquartered in Wilmington, Delaware. It provides a full spectrum of clinical trial, regulatory, and post-marketing services, spanning consulting, registration strategy, clinical study execution, and pharmacovigilance across Europe and Asia. Its geographic reach includes the EAEA Region and Europe, with operations in Latvia, Lithuania, Estonia, Serbia, Slovakia, Hungary, Germany, Spain, Türkiye, India, Pakistan, and China.

The firm promotes a one-stop service model, coordinating activities from planning to product registration under a professional team and adhering to ISO 9001:2015 for vendor management. Its clients include leading pharmaceutical, biotech, and R&D organizations across Europe, the United States, the CIS, and the Asia-Pacific region, and the company maintains ISO certifications for quality, information security, and business continuity.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2008
Employees
51-200

Section iconFunding & Financials

  • $1B - $10B

    Smooth Drug Development, next generation e-CRO in the US, Europe and Asia's revenue is estimated to be in the range of $1B - $10B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.